World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
58
Citations
11381
World Ranking
13242
National Ranking
5639

Overview

Michael A. McDevitt is affiliated with Johns Hopkins University in the United States and works at the intersection of medicine and social sciences. Their research spans medicine with a focus on oncology and communication-related fields, including political science and international relations. They have contributed to both biomedical and social scientific literature.

McDevitt's main fields of study include:

  • Medicine
  • Social Sciences

Their research extends into several subfields such as oncology, communication, political science and international relations, radiology, nuclear medicine and imaging, as well as sociology and political science.

  • Oncology
  • Communication
  • Political Science and International Relations
  • Radiology, Nuclear Medicine and Imaging
  • Sociology and Political Science

Michael A. McDevitt's work covers a range of topics, blending medical research with media and political studies. These topics include:

  • Monoclonal and Polyclonal Antibodies Research
  • Social Media and Politics
  • Media Studies and Communication
  • Cancer Immunotherapy and Biomarkers
  • Immunotherapy and Immune Responses
  • CAR-T cell therapy research
  • Populism, Right-Wing Movements

Among their recently published papers where they are an author are:

  • "Journalism and Democratic Backsliding: Critical Realism as a Diagnostic and Prescription for Reform," 2022, Political Communication
  • "An Overdue Contribution: Mass Communication Theory in the Security of Democracy," 2022, Mass Communication & Society

The broader collection of recent papers connected to their research environment includes studies in cancer immunotherapy and clinical oncology, such as:

  • "Phase I study of ABBV-428, a mesothelin-CD40 bispecific, in patients with advanced solid tumors," 2021, Journal for ImmunoTherapy of Cancer
  • "Dynamics of mutations in patients with essential thrombocythemia treated with imetelstat," 2020, Haematologica
  • "A phase I study of CD40 agonist ABBV-927 plus OX40 agonist ABBV-368 with or without the PD-1 inhibitor budigalimab in patients with advanced solid tumors," 2020, Journal of Clinical Oncology

Frequent collaborators in Michael A. McDevitt's work include:

  • William R. Henner
  • Hua Fang
  • Maulik Patel
  • Joel S. Hayflick
  • Martha Blaney

Michael A. McDevitt has published in several venues, with multiple works appearing in Blood and Cancer Research, along with contributions to journals focused on immunotherapy, political communication, and mass communication.

  • Blood
  • Cancer Research
  • Journal for ImmunoTherapy of Cancer
  • Political Communication
  • Mass Communication & Society

In addition to articles, McDevitt has authored at least one book published by Oxford University Press titled Where Ideas Go to Die (2020), addressing themes intersecting media and communication.

Best Publications

  • Acquired mutations in GATA1 in the megakaryoblastic leukemia of Down syndrome.

    Joshua Wechsler;Marianne Greene;Michael A. McDevitt;John Anastasi

  • A lineage‐selective knockout establishes the critical role of transcription factor GATA‐1 in megakaryocyte growth and platelet development

    Ramesh A. Shivdasani;Yuko Fujiwara;Yuko Fujiwara;Yuko Fujiwara;Michael A. McDevitt;Stuart H. Orkin

  • Loss of heterozygosity 4q24 and TET2 mutations associated with myelodysplastic/myeloproliferative neoplasms.

    Anna M. Jankowska;Hadrian Szpurka;Ramon V. Tiu;Hideki Makishima

  • 250K Single Nucleotide Polymorphism Array Karyotyping Identifies Acquired Uniparental Disomy and Homozygous Mutations, Including Novel Missense Substitutions of c-Cbl, in Myeloid Malignancies

    Andrew J Dunbar;Lukasz P Gondek;Christine L O'Keefe;Hideki Makishima

  • Mutational spectrum analysis of chronic myelomonocytic leukemia includes genes associated with epigenetic regulation: UTX, EZH2, and DNMT3A

    Anna M. Jankowska;Hideki Makishima;Ramon V. Tiu;Hadrian Szpurka

  • Risk-stratified outcomes of nonmyeloablative, HLA-haploidentical BMT with high-dose posttransplantation cyclophosphamide

    Shannon R. McCurdy;Jennifer A. Kanakry;Margaret M. Showel;Hua Ling Tsai

  • Somatic SETBP1 mutations in myeloid malignancies

    Hideki Makishima;Kenichi Yoshida;Nhu Nguyen;Bartlomiej Przychodzen

  • Abnormalities of the large ribosomal subunit protein, Rpl35a, in Diamond-Blackfan anemia.

    Jason E. Farrar;Michelle Nater;Emi Caywood;Michael A. McDevitt

  • Outcomes of Nonmyeloablative HLA-Haploidentical Blood or Marrow Transplantation With High-Dose Post-Transplantation Cyclophosphamide in Older Adults

    Yvette L. Kasamon;Javier Bolaños-Meade;Gabrielle T. Prince;Hua Ling Tsai

  • Requirement of a downstream sequence for generation of a poly(A) addition site

    Michael A. McDevitt;Michael J. Imperiale;Haseeb Ali;Joseph R. Nevins

  • A “knockdown” mutation created by cis-element gene targeting reveals the dependence of erythroid cell maturation on the level of transcription factor GATA-1

    Michael A. McDevitt;Ramesh A. Shivdasani;Yuko Fujiwara;Yuko Fujiwara;Haidi Yang

  • Kruppel-Like Factor 4 Is Essential for Inflammatory Monocyte Differentiation In Vivo

    Jonathan K. Alder;Robert W. Georgantas;Richard L. Hildreth;Ian M. Kaplan

  • Copy neutral loss of heterozygosity: a novel chromosomal lesion in myeloid malignancies

    Christine O'Keefe;Michael A. McDevitt;Jaroslaw P. Maciejewski

  • Mutations of E3 Ubiquitin Ligase Cbl Family Members Constitute a Novel Common Pathogenic Lesion in Myeloid Malignancies

    Hideki Makishima;Heather Cazzolli;Hadrian Szpurka;Andrew Dunbar

  • Prognostic impact of SNP array karyotyping in myelodysplastic syndromes and related myeloid malignancies.

    Ramon V. Tiu;Lukasz P. Gondek;Christine L. O'Keefe;Paul Elson

  • Novel homo- and hemizygous mutations in EZH2 in myeloid malignancies.

    Hideki Makishima;A M Jankowska;R V Tiu;Hadrian Szpurka

  • Single-agent GVHD prophylaxis with posttransplantation cyclophosphamide after myeloablative, HLA-matched BMT for AML, ALL, and MDS

    Christopher G. Kanakry;Hua Ling Tsai;Javier Bolaños-Meade;B. Douglas Smith

  • Sequences capable of restoring poly(A) site function define two distinct downstream elements.

    M.A. McDevitt;R.P. Hart;W.W. Wong;J.R. Nevins

  • Telomerase Inhibitor Imetelstat in Patients with Essential Thrombocythemia

    Gabriela M. Baerlocher;Elisabeth Oppliger Leibundgut;Oliver G. Ottmann;Gary Spitzer

  • CBL, CBLB, TET2, ASXL1, and IDH1/2 mutations and additional chromosomal aberrations constitute molecular events in chronic myelogenous leukemia

    Hideki Makishima;Anna M. Jankowska;Michael A. McDevitt;Christine O'Keefe

Frequent Co-Authors

Jaroslaw P. Maciejewski
Jaroslaw P. Maciejewski Cleveland Clinic
Mikkael A. Sekeres
Mikkael A. Sekeres Cleveland Clinic
Judith E. Karp
Judith E. Karp Johns Hopkins University
B. Douglas Smith
B. Douglas Smith Johns Hopkins University
Mark J. Levis
Mark J. Levis Johns Hopkins University
James G. Herman
James G. Herman University of Pittsburgh
Alan F. List
Alan F. List Precision BioSciences
Richard J. Jones
Richard J. Jones Johns Hopkins University
Ghulam J. Mufti
Ghulam J. Mufti King's College London
Seishi Ogawa
Seishi Ogawa Kyoto University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Biology or Biochemistry in the USA opens the door to diverse careers. Many students expand their options through related fields that blend lab science with health information, coding, or nutrition.

Medical coding and billing is a popular path for those who wish to combine healthcare with technology. If you are curious about medical coding jobs salary, you’ll find steady demand and good earning potential, especially as healthcare records move toward digitization. However, it’s important to consider the work-life balance and daily job duties before deciding if is medical billing and coding worth it.

Another growing field is Health Information Management. Pursuing an him degree online is an affordable and flexible way to enter a data-focused healthcare career. If your biology background leans toward nutritional science, a nutrition masters online can also offer rewarding professional opportunities in wellness, education, or clinical practice.

These degree pathways can align perfectly with a foundation in Biology or Biochemistry, opening doors to both hands-on and analytical careers in the expanding health and science sectors.

Best Scientists Citing Michael A. McDevitt

Trending Scientists